GenomeQuest Upgrades Online Patent Searching

Share Article

Comprehensive, Online IP Research Solution Gets Improvements in Global Content, Search Algorithms, and Analysis Tools

With GenomeQuest for IP, pharmaceutical firms, biotech companies, and academia can use GenomeQuest as an integrated solution for all their IP sequence searching needs.

GenomeQuest today announced the immediate availability of GenomeQuest 6.3 for IP -- the latest version of its online IP sequence search product.

Overall GenomeQuest for IP offers researchers a comprehensive, easy-to-use research solution with unmatched content aggregation, search algorithms, and analysis tools. New capabilities offered in the 6.3 version include:

-- Integration of DNA and Protein Searching -- researchers can now search IP databases of nucleotides and associated proteins simultaneously. The combined set of matches can be queried and analyzed as a single results database, saving time and errors associated with manually combining two different sets of results.

-- Content Expansion -- over 265,000 patents are now stored in the GQ-PAT database, including sequences and all annotations. GQ-PAT now aggregates, normalizes, curates, and updates IP information across global databases, including USPTO, EPO, WIPO & PCT, INPADOC, GenBank, EMBL, DDBJ, and paper filings at WIPO.

-- Enhanced Search and Analysis -- GQ-PAT offers multiple search algorithms, including BLAST, GenePast, and more. Each algorithm is suited to a different use case and works across the selected set of global databases.

-- The result browser has been upgraded to the GenomeQuest 6.0 platform, allowing users to interactively query/filter/group on any field, quickly pinpoint matches of most interest, and generate comprehensive IP search reports. Multiple users can collaborate on shared datasets.

CEO Ron Ranauro comments, "With GenomeQuest for IP, pharmaceutical firms, biotech companies, and academia can use GenomeQuest as an integrated solution for all their IP sequence searching needs, including for IP validity, freedom-to-operate, and patent infringement. In fact, most are finding that by using GenomeQuest for IP they can perform all research from a web browser with zero IT costs and administration, increasing their productivity, and boosting the quality and frequency of their searches."

Additionally, GenomeQuest 6.3 for IP gives life sciences professionals Web-based access to Thomson Reuters’ GENESEQ database. The two companies are hosting free seminars to present that latest features and seamless integration between the two products, in South San Francisco (June 10) and Boston (June 22). More information is available at http://www.genomequest.com/60/events.

To find out more about GenomeQuest for IP and to register for a free basic account, go to GenomeQuest.com.

About GenomeQuest

GenomeQuest, the leader in sequence data management (SDM) helps genomic researchers and their organizations make great discoveries far faster. Over 160 leading life science companies use GenomeQuest for mission-critical work, including 17 of the top 20 pharmaceuticals.

Using GenomeQuest, organizations improve the performance of their discovery process and broadly prepare for next generation sequencing (NGS). Researchers perform discoveries, manage and share sequence data, and access the world's largest collection of reference databases from a web-browser and personalized dashboard. Bioinformatics managers customize discovery workflows and unify their sequence data environment using the open platform APIs. IT and business managers efficiently scale to broad utilization of next generation sequencing in their discovery operations using the GQ-Engine.

Learn more at http://www.GenomeQuest.com.

Contact:
Dana Wormer, +1 215.888.0960

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Dana Wormer
Visit website